Montril Tablet 10 mg

Montril (Montelukast Sodium 10 mg) is a prescription tablet manufactured by Aristopharma Ltd, designed to manage asthma and allergic rhinitis. Priced at ৳17.50 per tablet, it offers cost-effective treatment with a pack of 3×10 tablets available for ৳525.00. This tablet form ensures easy administration for patients of various age groups.

As a leukotriene receptor antagonist, Montril blocks inflammation-causing chemicals in airways. It’s prescribed for preventing asthma attacks, exercise-induced bronchoconstriction, and seasonal/perennial allergic rhinitis. The drug works by inhibiting cysteinyl leukotriene receptors, reducing airway edema and muscle constriction linked to respiratory disorders.

Dosage guidelines vary by age:

• Adults: 10 mg daily
• Children (6-14 years): 5 mg daily
• Infants (6 months-5 years): 4 mg daily

Take once daily, preferably at night, or 2 hours before exercise. It can be consumed with/without food.

Common side effects include headache, diarrhea, and nausea. Rare but severe reactions involve mood changes, liver issues, or suicidal thoughts. Store below 30°C, shielded from light/moisture. Consult a doctor if pregnant or breastfeeding, as Montril passes into breast milk.

Explore Montelukast Sodium alternatives like Montril 4 mg/5 mg. Always follow prescribed guidelines to minimize risks and ensure therapeutic efficacy for respiratory conditions.

Adults 15+ years: 10 mg once daily. Children 6-14 years: 5 mg, 6 months-5 years: 4 mg. Take in evening for asthma/rhinitis or 2 hours before exercise. Can be taken with/without food. Do not use long-term without medical supervision.

Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.

Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.

Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.

Limited pregnancy data. Use under medical supervision. Caution during lactation. Follow physician advice to minimize infant risk.

Not for acute asthma attacks. Monitor psychiatric symptoms (anxiety, suicidality). Use cautiously in hepatic impairment. Regular monitoring required if bleeding disorders exist.

Safety not established for infants <6 months. Dose adjustments may needed in elderly/hepatic-renal impairment. No specific guidelines for dialysis patients.

There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Montril and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.